TSHA

Taysha Gene Therapies, Inc. · NASDAQ

Sector Health Technology
Industry Biotechnology
Website ayshagtx.com
Employees(FY) 65
ISIN US8776191061

Performance

-17.78%

-12.74%

-15.53%

-37.71%

+4.52%

YTD

+30.28%

Profile

Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for the treatment of CLN7 disease; TSHA-118 for the treatment of CLN1 disease; TSHA-105 for the treatment of for SLC13A5 Deficiency; and TSHA-101 for the treatment of GM2 gangliosidosis. Taysha Gene Therapies, Inc. has a strategic partnership with The University of Texas Southwestern Medical Center to develop and commercialize transformative gene therapy treatments. The company was incorporated in 2019 and is based in Dallas, Texas.

Advanced Technical Analysis

Technical Analysis of TSHA 2024-12-20

The stock indicators reflect a bearish sentiment overall, with a Moving Average Score of 10 indicating strong downward momentum, an Oscillators Score of 40 suggesting a neutral stance, and a Technical Score of 25 reinforcing the bearish outlook. This combination points to a challenging environment for the stock, with potential for further declines.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of TSHA

Stock Rank

Recent News & Updates

2024-12-06 08:00
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)(GlobeNewswire)
2024-12-05 19:00
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)(Globenewswire)
2024-11-15 08:46
Taysha Gene Therapies Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags(Simply Wall St.)
2024-11-13 23:51
Q3 2024 Taysha Gene Therapies Inc Earnings Call(Yahoo Finance)
2024-11-13 16:01
Taysha Gene Therapies Reports Third Quarter 2024 Financial Results and Provides Corporate Update(GlobeNewswire)
2024-11-13 13:16
Taysha Gene Therapies Inc (TSHA) Q3 2024 Earnings Call Highlights: Clinical Progress and ...(Yahoo Finance)
2024-11-13 04:15
Taysha Gene Therapies, Inc. (TSHA) Reports Q3 Loss, Lags Revenue Estimates(Yahoo Finance)
2024-11-13 03:01
Taysha Gene Therapies Reports Third Quarter 2024 Financial Results and Provides Corporate Update(Globenewswire)
2024-11-11 19:04
US Penny Stocks To Watch In November 2024(Simply Wall St.)
2024-11-06 08:00
Taysha Gene Therapies to Release Third Quarter 2024 Financial Results and Host Conference Call and Webcast On November 13(GlobeNewswire)
2024-11-05 19:00
Taysha Gene Therapies to Release Third Quarter 2024 Financial Results and Host Conference Call and Webcast On November 13(Globenewswire)
2024-11-01 16:30
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)(GlobeNewswire)
2024-11-01 04:30
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)(Globenewswire)
2024-10-21 20:00
Taysha Gene Therapies to Present Biodistribution Data from an Analysis Evaluating AAV9 Gene Therapy Delivery at the Upcoming 31st Annual ESGCT Congress(Globenewswire)
2024-10-16 03:42
Is Taysha Gene Therapies, Inc. (TSHA) the Most Promising Biotech Stock According to Hedge Funds?(Yahoo Finance)
2024-10-14 00:00
Taysha Gene Therapies (TSHA) Upgraded to Strong Buy: Here's Why(Yahoo Finance)
2024-10-03 20:01
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)(Globenewswire)
2024-10-02 16:55
Is Taysha Gene Therapies, Inc. (TSHA) the Best NASDAQ Stock Under $5?(Yahoo Finance)
2024-09-25 20:00
Taysha Gene Therapies Announces Oral Presentation on TSHA-102 in Rett Syndrome at Upcoming 9th World Rett Syndrome Congress(Globenewswire)
2024-09-06 08:00
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)(GlobeNewswire)
2024-09-05 20:00
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)(Globenewswire)
2024-08-18 09:45
Taysha Gene Therapies Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag(Simply Wall St.)
2024-08-12 08:01
Taysha Gene Therapies Reports Second Quarter 2024 Financial Results and Provides Corporate Update(GlobeNewswire)
2024-08-11 21:10
Taysha Gene Therapies, Inc. (TSHA) Reports Q2 Loss, Lags Revenue Estimates(Yahoo Finance)
2024-08-11 20:01
Taysha Gene Therapies Reports Second Quarter 2024 Financial Results and Provides Corporate Update(Globenewswire)
2024-08-11 10:02
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) has caught the attention of institutional investors who hold a sizeable 46% stake(Simply Wall St.)
2024-08-05 08:00
Taysha Gene Therapies to Release Second Quarter 2024 Financial Results and Host Conference Call and Webcast on August 12(GlobeNewswire)
2024-08-04 20:00
Taysha Gene Therapies to Release Second Quarter 2024 Financial Results and Host Conference Call and Webcast on August 12(Globenewswire)
2024-08-02 08:00
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)(GlobeNewswire)
2024-08-01 20:00
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)(Globenewswire)

Page 1 of 7

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.